Filing Flows › TransMedics Group (TMDX) › Capital expenditures
TransMedics Group (TMDX) capital expenditures by quarter
TransMedics Group's capital expenditures were $8.4M in Q3 2026 (third quarter 2026), +18% from Q2 2026. Over the last 6 quarters it ranged from $7.1M (Q2 2026) to $36.7M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $8.4M | +18% | +10% |
| Q2 2026 | $7.1M | -81% | -22% |
| Q1 2026 | $36.7M | +136% | — |
| Q4 2025 | $15.5M | +103% | — |
| Q3 2025 | $7.6M | -16% | — |
| Q2 2025 | $9.1M | — | — |
Q3 2026 at a glance
TransMedics Group, Q3 2026: revenue $203M (+41% year over year), operating margin 13.9%, net earnings $17.1M, operating cash flow $36.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is TransMedics Group's capital expenditures?
TransMedics Group's capital expenditures were $8.4M in Q3 2026 (third quarter 2026), +18% from Q2 2026.
How has TransMedics Group's capital expenditures changed?
Over the last 6 quarters it ranged from $7.1M (Q2 2026) to $36.7M (Q1 2026).